首页> 外文期刊>科儀新知 >Drug Screening System by Microcantilever Biochip
【24h】

Drug Screening System by Microcantilever Biochip

机译:微悬臂生物芯片药物筛选系统

获取原文
获取原文并翻译 | 示例
           

摘要

Taiwan, located in the subtropical region, is one of the major epidemic areas of Japanese encephalitis, dengue fever and enterovirus. There is still no effective drug or vaccine that can truly cure the mentioned-above infectious diseases until now. It is the first priority to understand the infection processes of the viruses in order to find effective antiviral drugs or vaccines. Most traditional methods have to use large equipments located in the laboratory to detect or analyse virus. Although they have accurate detection abilities, but also have many disadvantages like long detection time, large volume of samples and reagents, non-real time, expensive cost. This study has proposed a novel system to record completed infection processes of Japanese encephalitis, dengue fever and enterovirus. Meanwhile, the inhibiting ability of antibody or antiviral drug has studied also by the same system. The system is consisted of a biochip manufactured by MEMS technology, optical measurement platform, and biocompatible hydrogel material. The biochip size is 3.15 x 3.15 cm which is consisted of microcantilever beams with hydrogel and a PDMS microfluidic. The biochip successfully recorded infection processes of different viruses in different concentrations. It was found that Japanese encephalitis had obvious penetration, replication and separation stages. Furthermore, dengue fever virus, which is the same genus as Japanese encephalitis, had a similar infection process. In view of the detection results, for each of the virus mentioned above, the effective specific antibody and the ineffective non-specific antibody were respectively injected into the biochips along with the virus. The antivirus ability of the antibodies was verified within few hours. The tedious work and the time cost by traditional immunoassay were avoided. In addition, the antiviral drug, algae extract, was proved that it could inhibit dengue fever virus for few hours. This study had proved that the biochip and detection system could successfully record completed infection processes for different virus and drug screen. It is believed that the experiment results described above are helpful for drug screen, functional food, and vaccine discovery.
机译:台湾位于亚热带地区,是日本脑炎,登革热和肠病毒的主要流行地区之一。迄今为止,还没有有效的药物或疫苗能够真正治愈上述传染病。为了找到有效的抗病毒药物或疫苗,了解病毒的感染过程是第一要务。大多数传统方法必须使用实验室中的大型设备来检测或分析病毒。尽管它们具有准确的检测能力,但是也具有许多缺点,例如检测时间长,样品和试剂的体积大,实时性差,成本高。这项研究提出了一种新颖的系统来记录日本脑炎,登革热和肠病毒的完整感染过程。同时,还通过相同的系统研究了抗体或抗病毒药物的抑制能力。该系统由MEMS技术制造的生物芯片,光学测量平台和生物相容性水凝胶材料组成。生物芯片尺寸为3.15 x 3.15厘米,由带有水凝胶的微悬臂梁和PDMS微流体组成。该生物芯片成功记录了不同浓度的不同病毒的感染过程。发现日本脑炎具有明显的渗透,复制和分离阶段。此外,与日本脑炎属相同的登革热病毒具有相似的感染过程。考虑到检测结果,对于上述每种病毒,将有效特异性抗体和无效非特异性抗体与病毒一起分别注入生物芯片中。在数小时内验证了抗体的抗病毒能力。避免了传统免疫测定的繁琐工作和时间成本。此外,已证明抗病毒药藻提取物可在数小时内抑制登革热病毒。这项研究证明,该生物芯片和检测系统可以成功记录针对不同病毒和药物筛选的完整感染过程。相信上述实验结果对药物筛选,功能食品和疫苗发现有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号